After decades when only higher primates had been found in the Oligocene deposits of the Fayum, Egypt, a few isolated teeth of prosimians and a partial mandible of a tarsier were discovered there in the 1980s. These, assigned to the families Lorisidae, Omomyidae and a new genus and species, Afrotarsius chatrathi, are discussed and reviewed. Since 1990, a late Eocene locality in the Fayum, L-41, has been intensively explored, and in this older site a new suite of archaic higher primates has been recovered. Together with these anthropoideans, material of at least three new prosimians has been found. A skull and mandibles of the most complete of these, Plesiopithecus teras, was described in 1994. This appears to be the oldest strepsirhine yet discovered worldwide, and it has been assigned a position as a sister-group to the Lorisidea. In 1995, a cercamoniine adapid, Aframonius dieides, was also described from L-41. The description of a third new genus and species of prosimian from L-41 is presently in preparation. The previously described prosimians are here reviewed and their implications for understanding the overall prosimian radiation discussed.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.